D-Chiro-Inositol

D-Chiro-Inositol (DCI ≥95%-98% HPLC / Natural Carob Pod Derived) | Gold Standard Active for Insulin Sensitivity, Glycogen Synthesis & 40:1 PCOS Harmony

1. Product Overview & Value Proposition

D-Chiro-Inositol (DCI, 1D-chiro-Inositol, D-手性肌醇), one of the nine stereoisomeric configurations of cyclohexanehexol and an essential functional partner to Myo-Inositol, represents a cornerstone active in human endocrinology, metabolic glucose regulation, and reproductive health. In mammalian physiology, D-Chiro-Inositol is not synthesized de novo from scratch; rather, it is generated from Myo-Inositol through the action of an insulin-dependent NAD/NADH epimerase enzyme according to specific tissue metabolic requirements. While Myo-Inositol predominates in high-metabolic-turnover tissues and inside the ovarian follicle to govern cellular glucose uptake and FSH signaling, D-Chiro-Inositol is heavily concentrated in glycogen storage depots—principally the liver, skeletal muscle, and adipose tissue.

Biochemically, D-Chiro-Inositol forms the core saccharide moiety of inositol phosphoglycans (IPG-A-type), the distinct second-messenger cascade that directly triggers the dephosphorylation and activation of glycogen synthase and pyruvate dehydrogenase. This promotes the intracellular conversion of blood glucose into stored glycogen, facilitating postprandial glucose disposal without placing excessive secretory burden on pancreatic beta-cells. In conditions of metabolic dysfunction and peripheral insulin resistance (such as type 2 metabolic syndrome and Polycystic Ovary Syndrome), systemic epimerase activity becomes severely impaired, preventing the normal peripheral conversion of Myo-Inositol into DCI and resulting in cellular DCI depletion. Delivering bio-available bulk D-Chiro-Inositol powder restores cellular second-messenger reserves, enhances systemic insulin signaling, and balances metabolic pathways across primary commercial sectors:

• The Gold-Standard 40:1 Physiological PCOS Formulations: Combined with Myo-Inositol at the scientifically validated 40:1 ratio (2,000 mg Myo-Inositol to 50 mg D-Chiro-Inositol), it mimics healthy human plasma levels, improving systemic insulin sensitivity while avoiding the follicular androgen toxicity observed with high-dose standalone DCI.
• Metabolic Glucose Disposal Agents (GDA) & Anti-Glycation Capsules: Accelerates peripheral carbohydrate partitioning into skeletal muscle glycogen stores, lowering postprandial insulin surges and preventing advanced glycation end-products (AGEs).
• Female Endocrine & Cycle Regularity Complexes: Alleviates peripheral insulin resistance, dampening compensatory hyperinsulinemia to lower circulating ovarian androgen synthesis and support dermatological skin clarity (mitigating hormonal acne and hirsutism).
• Functional Wellness Beverages & Drink Sticks: Highly water-soluble, thermally stable, and non-hygroscopic, allowing clean integration into daily metabolic sachets, effervescent drink mixes, and adaptogenic morning coffee blends.

As an established bulk D-Chiro-Inositol manufacturer and direct active ingredient supplier, we extract our material from non-GMO mature carob pods (*Ceratonia siliqua*) and tartary buckwheat using closed-loop hydro-ethanolic extraction, continuous chromatographic separation, and controlled vacuum crystallization. To empower agile brands and contract manufacturing organizations (CMOs), we pair uncompromising analytical quality with flexible commercial terms: accessible low MOQ procurement for benchtop pilot trials, multi-ingredient shipment consolidation across our female vitality, metabolic active, and longevity catalog, and dedicated on-the-ground China-wide raw material sourcing assistance tailored to your exact manufacturing requirements.

2. Product Specifications (Analytical Quality)

3. Functional Applications (Mechanism of Action)

Deploying pharmaceutical-grade D-Chiro-Inositol across female hormonal regimens, metabolic glucose disposal agents, and functional nutritional blends provides scientifically validated cellular mechanisms:

• Activation of Glycogen Synthase via IPG-A-Type Mediators: Inside hepatocytes, myocytes, and adipocytes, D-Chiro-Inositol acts as the active structural component of inositol phosphoglycan A-type (IPG-A) second messengers. Following insulin receptor binding, IPG-A is cleaved into the cytosol, where it directly activates glycogen synthase phosphatase, driving the dephosphorylation and activation of glycogen synthase to channel intracellular glucose into glycogen storage.
• Reduction of Compensatory Hyperinsulinemia: By accelerating non-oxidative glucose disposal in peripheral tissues, DCI improves systemic insulin sensitivity. Lowering circulating insulin levels attenuates the abnormal insulin stimulation of ovarian theca cells, reducing excess ovarian cytochrome P450c17α activity and decreasing androgen overproduction.
• The Critical “Ovarian Paradox” and 40:1 Ratio Synergy: Unlike muscle and liver tissue, the healthy ovary maintains a very low concentration of DCI and high levels of Myo-Inositol (approximate 100:1 ratio in follicular fluid). In insulin-resistant PCOS, compensatory hyperinsulinemia over-stimulates ovarian epimerase, causing an excessive intra-ovarian conversion of Myo-Inositol into DCI. This leads to a severe local depletion of Myo-Inositol and impairs oocyte maturation. Supplementing with the 40:1 physiological ratio (2,000 mg Myo-Inositol + 50 mg D-Chiro-Inositol) provides just enough DCI to restore peripheral insulin sensitivity and hepatic glycogen storage without oversaturating the ovary or compromising follicular quality.
• Mitigation of Hyperandrogenic Manifestations: By lowering systemic insulin resistance and restoring normal theca-granulosa cell communication, DCI supplementation downregulates free circulating testosterone and dehydroepiandrosterone sulfate (DHEA-S), visibly reducing manifestations of hyperandrogenism such as inflammatory cystic acne, facial hirsutism, and androgenic alopecia.
• Lipid Profile Optimization & Hepatic Steatosis Support: Activates hepatic AMP-activated protein kinase (AMPK) signaling, downregulating sterol regulatory element-binding protein-1c (SREBP-1c). This reduces hepatic de novo lipogenesis, decreases serum triglycerides, and mitigates intrahepatic lipid accumulation.
• Neutral Formulation Profile in Functional Beverages & Coffee: D-Chiro-Inositol is completely odorless, exhibits a very clean, mild, non-lingering sweetness, and dissolves instantly in water without turbidity. It withstands pasteurization and brewing temperatures (melting point 250°C–255°C), integrating effortlessly into functional coffees, metabolic drink sticks, and fertility teas.

4. Formulation Combinations & Trending Market Applications

Capitalize on the expanding female endocrine wellness, metabolic GDA, and fertility markets by formulating with our high-purity D-Chiro-Inositol active:

• The Clinically Benchmark “40:1 Ratio” PCOS & Hormonal Balance Complex: Our D-Chiro-Inositol (Clinical Grade ≥98%, 50 mg) + Myo-Inositol (USP Grade ≥99%, 2,000 mg) + Calcium L-5-Methyltetrahydrofolate (400 μg DFE) + Coenzyme Q10 (Ubiquinol 98%, 100 mg) + Zinc Glycinate (15 mg elemental Zn). The globally recognized gold-standard clinical formula: restores the natural 40:1 physiological circulating ratio, accelerates peripheral glucose disposal, optimizes follicular maturation, and provides methylation support without hormonal side effects.
• The Advanced Carbohydrate-Partitioning & Glucose Disposal Agent (GDA) Stack: Our D-Chiro-Inositol (100–200 mg) + Berberine Hydrochloride (≥98%, 500 mg) + Fenugreek Seed Extract (4-Hydroxyisoleucine 20%, 200 mg) + Alpha-Lipoic Acid (ALA 300 mg) + Chromium Picolinate (200 μg). An elite non-stimulant metabolic capsule engineered to shuttle dietary carbohydrates directly into skeletal muscle glycogen reserves, reduce postprandial glucose spikes, and prevent fat storage.
• The Hormonal Clear Skin & Anti-Androgen Complex: Our D-Chiro-Inositol (50 mg) + Myo-Inositol (1,000 mg) + Saw Palmetto 45% CWS Powder (160 mg) + Spearmint Leaf Extract (10:1, 200 mg) + Vitamin B6 (P-5-P, 25 mg). A targeted oral beauty-from-within formula designed to calm sebaceous gland hyperactivity, block 5-alpha-reductase conversion to DHT, and clear hormonal jawline acne.
• The “Metabolic Balance” Morning Mushroom Coffee Sachet: Our D-Chiro-Inositol (50 mg) + Myo-Inositol (1,000 mg) + Lion’s Mane Mushroom Extract (Beta-Glucan 30%, 300 mg) + Cordyceps Militaris Extract (Cordycepin 1%, 300 mg) + Micro-Ground Arabica Coffee. A daily functional brew designed to smooth morning glucose dynamics, eliminate post-caffeine insulin drops, and support calm, sustained cognitive performance.

5. Why Choose Us As Your Long-Term Nutritional Active Partner?

• Flexible Low MOQ Policy: Mitigate product launch risk. As an agile low MOQ D-Chiro-Inositol bulk distributor, our orders start as low as 1 kg for high-purity crystalline powder (≥98%), scaling seamlessly to recurring multi-hundred kilogram and commercial ton-scale manufacturing contracts.
• Multi-Product Portfolio Consolidation: Streamline your procurement by sourcing your complete metabolic and female health suite (D-Chiro-Inositol, Myo-Inositol, Calcium L-5-Methyltetrahydrofolate, CoQ10, Berberine HCl, Alpha-Lipoic Acid), functional mushrooms (Lion’s Mane, Cordyceps), and longevity actives (β-NMN, Ca-AKG) under a single, cost-effective freight shipment to reduce customs overhead and landed freight costs.
• Value-Added China Sourcing Service: In addition to our dedicated carob extraction and crystallization facilities, our on-the-ground technical team audits upstream botanical cooperatives, validates HPLC-RI purity and specific optical rotation testing paperwork, and procures specialized functional ingredients across China tailored to your exact manufacturing roadmap.

6. Quality & Supply Chain Assurance

• 100% Non-GMO Botanical Origin (Carob Pod & Buckwheat): Extracted strictly from sustainable, non-GMO mature carob pods (*Ceratonia siliqua*) or tartary buckwheat. Completely free from synthetic chemical precursors or recombinant DNA.
• Absolute Optical Stereospecificity ([α]²⁰_D +60.0° to +65.0°): The physiological activity of chiro-inositol is strictly stereospecific. Synthetic or unrefined sources often contain biologically inactive L-chiro-inositol or pinitol impurities. We verify every commercial batch using Polarimetry and Chiral HPLC to guarantee 100% dextrorotatory D-chiro-inositol.
• High-Resolution HPLC-RI Chromatography: Because cyclitols lack conjugated double bonds for standard UV detection, every batch is analytically quantified using High-Performance Liquid Chromatography coupled with Refractive Index (HPLC-RI) or Charged Aerosol Detection (HPLC-CAD) to ensure accurate separation from Myo-Inositol and pinitol.
• Superior Physicochemical & Thermal Stability: Boasts an elevated melting point (250°C–255°C), non-hygroscopic crystalline behavior, and stability across pH 3.0 to 8.5, ensuring smooth automated encapsulation, uniform tableting, and complete stability in warm functional drink mixes.
• Comprehensive ICP-MS & Contaminant Screening: Batch-tested via high-resolution ICP-MS and GC-MS/MS to ensure heavy metals (Lead, Arsenic, Cadmium, Mercury) and agrochemical residues strictly comply with California Prop 65, USP <561>, and European Union food supplement pharmacopeial standards. Sealed in food/pharma-grade double-polyethylene liners within vacuum-sealed aluminum barrier pouches and heavy-duty 25 kg fiber export drums.

7. FAQ

Q1: Why is D-Chiro-Inositol rarely used at high doses alone for PCOS, and why is the 40:1 ratio essential?
A1: While D-Chiro-Inositol is vital for peripheral glucose disposal, scientific studies have shown that high doses of standalone DCI (e.g., >600–1,200 mg/day) can be counter-productive to ovarian health. In the ovary, excess DCI acts as an aromatase inhibitor, which can paradoxically elevate intra-follicular androgens and deteriorate oocyte quality. The physiological 40:1 Myo-to-D-Chiro ratio (2,000 mg Myo-Inositol to 50 mg DCI) provides the ideal biological synergy: DCI handles systemic insulin sensitivity, while Myo-Inositol supports healthy FSH signaling and egg quality within the ovary.

Q2: How does D-Chiro-Inositol activate cellular glycogen synthesis?
A2: D-Chiro-Inositol forms the core saccharide unit of inositol phosphoglycan A-type (IPG-A) second messengers. When insulin binds to its receptor on liver or muscle cell membranes, IPG-A is cleaved into the cytosol, where it directly dephosphorylates and activates glycogen synthase, accelerating the conversion of blood glucose into stored intracellular glycogen.

Q3: What is the botanical raw material source of D-Chiro-Inositol?
A3: D-Chiro-Inositol is naturally concentrated in the pods of the Mediterranean Carob tree (*Ceratonia siliqua*) and Tartary Buckwheat (*Fagopyrum tataricum*), where it exists naturally or as D-pinitol (a monomethyl ether of DCI). We extract our material from non-GMO carob pods using clean aqueous-ethanolic extraction, followed by catalytic demethylation and crystallization to produce pure, pharmaceutical-grade DCI.

Q4: What is the recommended daily dosage of D-Chiro-Inositol in dietary supplements?
A4: Formulation dosages vary based on the target physiological application:

• PCOS & Hormonal Balance (Paired with Myo-Inositol): 50 mg to 100 mg per day (accompanying 2,000 mg to 4,000 mg of Myo-Inositol to maintain the 40:1 ratio).
• Metabolic Glucose Disposal & Insulin Support: 100 mg to 200 mg per day.
• Hormonal Acne & Androgen Balance Formulations: 50 mg to 100 mg daily.

Q5: What is the MOQ for bulk D-Chiro-Inositol powder orders?
A5: We support agile commercialization with minimum order quantities starting from just 1 kg for pilot benchtop trials and formulation prototyping, scaling smoothly up to recurring multi-hundred kilogram commercial manufacturing contracts.

8. References

1. PubChem: D-Chiro-Inositol Compound Summary (CID 448173) – National Center for Biotechnology Information.
2. PubMed Central: The Role of Inositol Isomers and the 40:1 Ratio in Polycystic Ovary Syndrome: Endocrine Mechanisms and Clinical Review – National Institutes of Health research database.

Keywords you may search: bulk D-Chiro-Inositol supplier, DCI powder manufacturer, pure D-chiro-inositol 98 percent HPLC, carob pod extract DCI, 40 to 1 myo inositol d-chiro inositol raw material, insulin resistance DCI distributor, PCOS fertility supplement active ingredient, glucose disposal agent DCI bulk, low MOQ nutritional ingredient provider, custom China ingredient sourcing service, pure d-chiro-inositol bulk